PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study

Yves-Laurent Bayard1, MD; Heyder Omran2, MD; Petr Neuzil3, MD; Leif Thuesen4, MD; Maximilian Pichler5, MD; Edward Rowland6, MD; Angelo Ramondo7, MD; Witold Ruzyllo8, MD; Werner Budts9, MD; Gilles Montalescot10, MD; Pedro Brugada11, MD; Patrick W. Serruys12, MD; Alec Vahanian13, MD; Jean-François Piéchaud14, MD; Antonio Bartorelli15, MD; Jean Marco16, MD; Peter Probst17, MD; Karl-Heinz Kuck18, MD; Stefan H. Ostermayer1, MD; Fra